Project description
New technology broadens access to vaccines
Life-saving vaccines have long been dependent on the so-called cold chain, requiring refrigerators or freezers for transport and storage. This increases waste, their costs and carbon footprint while hindering access based on socioeconomic status or geographic location. The current pandemic has highlighted the complications of universal access associated with liquid vaccines requiring strict temperature control. The Swedish SME Ziccum has developed a pioneering technology to gently dry vaccines without harming them, enabling powdered formats. The EU-funded FORMBECC project is developing an industrial-scale version of this technology, facilitating intensive testing and validation to prepare for its commercialisation.
Objective
Formulation of sensitive drugs in a stable manner poses problems with currently applied technologies: the substances need to be either heated up to +80 °C or frozen to -80 °C. Many valuable biological pharmaceuticals need to be kept and transported in a liquid phase at fixed temperatures, which renders them impractical and costly. The global healthcare community, with the World Health Organisation in the lead, is looking for options to step out of the cold chain and provide more accessible medication to all communities.
In the LaminarPace project, Ziccum AB is developing a gentle, room temperature spray-drying technology for the application in the pharmaceutical industry. The system is operational on a laboratory scale and pilot-tested now. It could successfully lead to the development of new biologics: vaccines, drugs and therapies. An industrial-scale system based on the same principles of operation will be developed and commercialised. The objective is to set the large system into BioTech production lines. LaminarPace process is fully controllable according to Good Manufacturing Practice and produces carefully-engineered, stable and easily-absorbed formulations.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs vaccines
- engineering and technology chemical engineering chemical process engineering
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.3. - PRIORITY 'Societal challenges
See all projects funded under this programme -
H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
SME-1 - SME instrument phase 1
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-EIC-SMEInst-2018-2020
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
141 57 HUDDINGE
Sweden
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.